Print Page | Sign In | Join Today
Focus Around Virginia
Blog Home All Blogs
A word from John Newby, CEO, Virginia Bio: This blog provides an update on upcoming events and important information that impacts our community, and spotlights industry leaders from state-of-the-art companies and research institutions driving the future of bioscience around the state, our region and our world.

 

Search all posts for:   

 

Top tags: virginia bioscience  Virginia bio  funding  government  Economic Development  Governor  thrive  21st century cure  big data  commercialization  DARPA  federal  policy  Research  STEM  Todd Haymore  vabio  #biotech  #veterans #vamedicalcenter #g2gconsulting #biotech  agriculture  Biological  convention  IALR  Inova  Institute for Advanced Learning and Research  intern  JP Morgan Healthcare Conference  jpmorgan  medimmune  students 

Thank you

Posted By Administration, Thursday, December 19, 2019
Updated: Thursday, December 19, 2019

Members and Friends,

 

The New Year is nearly here!  In this brief Newsletter, your Virginia Bio team simply wants to THANK YOU for allowing us to partner with you and support all the wonderful things you are doing for our life sciences ecosystem in the Commonwealth! It has been an action-packed first 5 months for me and our team, highlighted by an extremely successful 4th Annual Women Building Bio Conference, and several exciting Commercialization Luncheon keynotes from Donna Edmonds (CEO, Brainbox), Reinhardt Eberl (CEO, Anton Paar),  David Alwood (CEO, FUJIFILM Wako Chemicals), and Dan Hathorn (Business Development Manager, ADS, Inc.).  We look forward to continuing our work into the New Year to bring even more useful programing, and to help bring life saving innovations to our Commonwealth and the world.

 

Keep your Equity! Member Benefit of Note-New Monthly Call Reporting on Non-Dilutive Funding Opportunities!  Augmenting the monthly GBG Report available to members listing these opportunities, our friends at G2G Consulting are going to provide monthly GBG Report Highlights Calls on the third Friday of the month at 10-10:30 am on their conference line: (202) 827-6334, no passcode needed.  On this call members will hear: (1) overview of new funding opportunities; (2) key categories for funding; (3) new items of interest; (4) tips for the application process; and (5) answers to questions on non-dilutive funding.  Please mark your calendars!

 

Virginia Bio Advocacy for the Industry: Two brief updates:

 

U.S. House of Representatives: Lower Drug Costs Now Act (H.R.3).  Many of you have been following this piece of legislation, which would make sweeping changes to our larger private health care system by granting the government authority to set medicine prices in public and private markets that will have a detrimental impact on future medical innovation.  This bill has passed the House and is awaiting a vote in the Senate, where it is expected to face major opposition and not pass.  Virginia Bio joined the Virginia Chamber of Commerce, the Greater Richmond Urban Collective and the Virginia Asian Chamber of Commerce on an October 17 PhRMA We Work for Health letter to each member of the Virginia Congressional Delegation advocating against HR3.  

 

Permanent Repeal of the Medical Device Tax.  The pending compromise Federal spending bill passed December 17 in the House contains provisions for a complete repeal of the Medical Device Tax.  It is now headed to the Senate where the spending bill is expected to pass, then to the President for signature, which will thus end the specter of this tax.  Virginia Bio joined MDMA and 615 other life science organizations and companies, including the Advanced Medical Technology Association (AdvaMed) and the Medical Imaging & Technology Alliance (MITA), on a September 24 letter to Congressional leaders urging a permanent repeal of the medical device tax. 

 

Upcoming Events.  We look forward to seeing you at our next Virginia Bioscience Commercialization Luncheon in Richmond, January 9, 2020, where I will be providing a Virginia General Assembly 2020 preview.  Come learn about issues being debated in the General Assembly that are critical to our industries.   We will open the forum to welcome your policy concerns and ideas for how Commonwealth and local governments can stimulate research and commercialization.  Virginia Bio will be stomping the General Assembly building all Session to represent you!

JPM 2020 is Here!  The Virginia Reception returns to the San Francisco Clift Hotel on January 12, 2020 to kick off the 38th J.P. Morgan Healthcare Conference.  The JPM Healthcare Conference is the largest healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.  Attendance at JPM 2020 is limited, so please be sure to mark your calendars and sign up here to reserve a free (for members) meeting room blocked time, available January 13-15.

Other events of note in 2020: We are also looking forward to attending the BIO Annual conference in San Diego, June 8-11; the BioHealth Captial Region Forum at AstraZenneca (Gaithersburg) April 15-16; and the 5th Annual Women Building Bio Conference in September. Please click here to keep apprised of all of Virginia Bio’s upcoming events.

Your Ideas.  Virginia Bio wants to hear from you!  Contact us at questions@vabio.org, your ideas, comments, suggestions and advice regarding how Virginia Bio can best support you and our biotechnology ecosystem.

 

Happy Holidays, and we look forward to seeing you in the New Year!

 

John, Cassandra and Caron

 

 

This post has not been tagged.

Share |
Permalink
 

Easing Budgets and Advocating for Members

Posted By Administration, Thursday, November 21, 2019
Updated: Thursday, November 21, 2019

Members and Friends,

Happy Holidays!

As we begin to ease ourselves into the holiday season, and as we busy ourselves with our Black Friday and Cyber Monday shopping plans all the while trying to stay on budget, Virginia Bio would like to remind you of the ways membership saves our companies major money! Virginia Bio is a BIO Business Solutions® (BBS) Affiliate, the largest cost savings purchasing program for the biotech industry operated by the Biotechnology Innovation Organization (BIO). With more than $400 million in annual sales, BBS aggregates the purchasing power of over 3,000 North American biotech companies. BBS offers members the opportunity to save on items they need to run a successful biotechnology enterprise - from lab products, business insurance, office supplies, shipping needs, and much more. Participating Virginia Bio members save from $5000 up to $300,000 per year with BBS, and saved more than $4.3 Million in 2018 utilizing this savings program! Click here for more details about the vendors available under this program and how you can maximize your own savings.


Virginia Bio Advocacy for the Industry
:
We have recently lent the voice of Virginia Bio to two very important issues affecting many of our members.

Virginia General Assembly’s Joint Commission on Healthcare Takes No Action on Drug Pricing Recommendations. You will recall that on September 25, Virginia Bio submitted comments on several policy proposals being considered by the Virginia General Assembly to, among other things: implement Virginia state government drug affordability board and upper pay limits, ban pay-to-delay agreements, and develop a program to import drugs from Canada. (You can see our letter, here). On November 14, the Joint Commission announced that it will take no action on any of the policy proposals it was considering. While this is positive news, we will monitor this issue throughout the 2020 General Assembly session and beyond.

U.S. House of Representatives: Lower Drug Costs Now Act (H.R. 3)
Many of you have been following this piece of legislation, which would make sweeping changes to our larger private health care system by granting the government authority to set medicine prices in public and private markets that will have a detrimental impact on future medical innovation. Virginia Bio joined the Virginia Chamber of Commerce, the Greater Richmond Urban Collective and the Virginia Asian Chamber of Commerce on an October 17 PhRMA We Work for Health letter to each member of the Virginia Congressional Delegation advocating against HR3 and international reference pricing for drugs. By example, you can see the letter addressed to Senator Mark Warner, here. The bill has passed out of the three committees having jurisdiction, and it is expected that the full House will consider the bill by the end of this month.


Gubernatorial Recognition of Cavion and Andrew Krouse
. On November 12, Governor Northam hosted a Leadership of Virginia’s Technology Research and Commercialization Reception at the Governor’s Mansion in Richmond. In attendance were myself, Board members Jim Powers (CEO, HemoShear Therapeutics), Elaine Horn-Ranney (CEO, Tympanogen), Rony Thomas (CEO, LifeNet Health), and keynote speaker Andrew Krouse, immediate past Board Chairman and CEO of recently-acquired Cavion, Inc. Andrew represented all of the companies then present who were being recognized for having competed for and received investment from the Commonwealth, and he described the growth of his company from a startup in his garage to being acquired by Jazz Pharmaceuticals for a total potential consideration of $312.5 million.


Upcoming Events. We look forward to seeing you at our next Virginia Bioscience Commercialization Luncheon in Richmond, December 12, featuring FUJIFILM Wako Chemicals U.S.A. President David Alwood, LAL Sales Specialist Jonathan Vaughn and Technical Specialist LaToya Mayfield. FUJIFILM Wako has long been recognized as a world-renowned supplier and continues to maintain a culture of product quality through the establishment Limulus Amebocyte Lysate for detection of gram negative bacterial endotoxins. Come learn about the corporation and how this unusual extract from the horseshoe crab can become a vital part of quality control for pharmaceuticals, medical devices, and much more!

On December 10 Virginia Bio, the Charlottesville Business Innovation Council and the UVA Licensing & Ventures Group will jointly host a Holiday Party, open to our entire life science community. The party will be held in Charlottesville at UVA L&VG, 722 Preston Avenue #107, 5:00 - 8:00 pm and will be a festive celebration with colleagues, delicious food and spirits. Join us if you can!

JPM 2020 is Here! Yes, we are still excited to again bring the Virginia Reception back to the San Francisco Clift Hotel’s Velvet Room on January 12, 2020 to kick off the 38th J.P. Morgan Healthcare Conference. The JPM Healthcare Conference is the largest healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. Attendance at JPM 2020 is limited (and hotel rooms even more so!), so please be sure to mark your calendars, make your hotel reservations, and be on the lookout for more information from Virginia Bio regarding meeting room reservations!


Your Ideas. Virginia Bio wants to hear from you! Please do not wait for the occasion of my visit with you to provide feedback; send us your ideas, comments, suggestions and advice regarding how Virginia Bio can best support you and our biotechnology ecosystem. Contact us at questions@vabio.org.

Happy Thanksgiving, and Kindest regards,



John

This post has not been tagged.

Share |
Permalink
 

JP Morgan Healthcare Conference....and more!

Posted By Administration, Thursday, October 24, 2019
Updated: Thursday, October 24, 2019

Members and Friends,

JPM 2020 is Here! Just five years ago, Virginia Bio held its first Virginia Reception at the San Francisco Clift Hotel’s Velvet Room during the 33rd Annual J.P. Morgan Healthcare Conference. Given its incredible success and impact upon our members, we have every year since continued the tradition, and we are proud to bring the Virginia Reception back to the Velvet Room on Sunday, January 12 for JPM 2020. The 38th J.P. Morgan Healthcare Conference will be held January 13-20, 2020 at the Westin St. Francis in San Francisco and is the largest healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. Attendees come from the entire global healthcare landscape, including pharmaceutical companies, healthcare service providers, profit and not-for-profits, and medical device companies. The Virginia Reception will be the kick-off to a great week, and has historically seen over 200 friends gather to share the story of Virginia’s biotechnology ecosystem and connect our members to the investor community. Connections made that evening and elsewhere roll into the following three days in reserved meeting spaces in the Clift Hotel provided by Virginia Bio, on a pre-reserved basis and at no cost to our members. Attendance at JPM 2020 is limited (and hotel rooms even more so!), so please be sure to mark your calendars, make your hotel reservations, and be on the lookout for more information from Virginia Bio regarding the Virginia Reception!

Virginia Bio Advocacy for the Industry: We have recently lent the voice of Virginia Bio to two very important issues affecting many of our members.

Permanent Repeal of the Medical Device Tax. Continuing an effort led by the Medical Device Manufacturers Association (MDMA) 2009, Virginia Bio joined MDMA and 615 other life science organizations and companies, including the Advanced Medical Technology Association (AdvaMed) and the Medical Imaging & Technology Alliance (MITA), on a September 24 letter to Congressional leaders urging a permanent repeal of the medical device tax. The 2.3% tax, imposed upon medical devices in 2013 and suspended in 2015, will be reimposed January 1, 2020 if not repealed. The adverse impact on R&D investment and job creation would jeopardize the U.S.’s position as a global leader in medical device innovation, and it is estimated that a reinstatement of the tax could result in the loss of 21,000 jobs. You can see the letter here.

Drug Pricing: Comments Submitted to the Virginia Joint Commission on Healthcare; Letter to Congress from 44 Trade Associations Opposing International Price Referencing. On September 25, Virginia Bio submitted comments on several policy proposals being considered by the Virginia General Assembly to, among other things: implement Virginia state government drug affordability Board and upper pay limits, ban pay-to-delay agreements, and develop a program to import drugs from Canada. Our comments opposing these ideas align with those submitted by BIO and PhRMA. You can see our letter here. Relatedly, Virginia Bio joined an October 16 letter, addressed to Congress and joined by 44 state and regional life sciences and biotechnology associations, opposing international price referencing or other price controls. You can see that letter here.

Upcoming Events. We look forward to seeing you at our next Virginia Bioscience Commercialization Luncheon in Richmond, November 14, featuring Donna Edmonds, CEO of BRAINBox Solutions, Inc. Donna will be discussing BRAINBox’s innovative biomarker panels, as well as neurocognitive testing, which provide objective evidence of traumatic brain injury and prediction of patient recovery. Join us to hear about her journey as a serial entrepreneur and CEO, her experience raising capital, and how she and her team are innovating a new generation of concussion testing.

As you are also viewing other events on our calendar, we call special attention to the Southeast BIO Investor & Partnering Forum (SEBIO), November 6-7 at the Biltmore Hotel in Miami/Coral Gables, Florida. SEBIO is the region’s leading life sciences and medical technology conference, connecting emerging companies with potential investors and corporate partners. Celebrating its 21st anniversary, the SEBIO Investor & Partnering Forum will feature new networking opportunities and expanded investment prospects.
 
Your Ideas. Virginia Bio wants to hear from you! My visits with our members and partners during these first few weeks have been enlightening and motivating! Please do not wait for the occasion of my visit with you to provide feedback; send us your ideas, comments, suggestions and advice regarding how Virginia Bio can best support you and our biotechnology ecosystem. Contact us at questions@vabio.org.

Kindest regards,

John

This post has not been tagged.

Share |
Permalink
 

What A Conference!

Posted By Administration, Friday, September 27, 2019
Updated: Thursday, September 26, 2019

Members and Friends,

The 4th Annual Women Building Bio conference was a fantastic gathering of leaders, innovators and motivators who exceeded all expectations for this fantastic event! It truly was a celebration, spotlighting the women building our industry and offering an incredible forum for collaboration, networking and community building.

The day started with a challenge by Sunita Dodani of Eastern Virginia Medical School, challenging us to think bigger, broader and unconventionally when seeking new collaborations. Julie Gerberding, M.D., M.P.H., the Chief Patient Officer of Merck & Co. continued the conversation by encouraging us to strengthen our industry and improving patient care by promoting diversity. The day continued with outstanding speakers and panels on health diagnosis; collaborations in the fight against metastatic breast cancer; innovations in neonatal healthcare; the STEM workforce; an engaging networking roundtable and personal views of the challenges and opportunities in building bioscience companies. The day concluded with a charge from Carilion Clinic CEO Nancy Howell Agee to positively affect the lives of patients, and an address on cultivating innovation by Michelle McMurry-Heath, Worldwide Vice President, Regulatory and Clinical Affairs at Johnson & Johnson, and Vice President, External Innovation, Regulatory Science, and Executive Director of Scientific Partnerships for JLABS@Washington, DC.

As you can see, the conference was action-packed! Check out a few pictures and highlights from our conference here. A hearty “Thank You” to all of our sponsors, and a special thanks to our partners at the Inova Center for Personalized Health in Fairfax for providing a wonderful venue for this most important event. We look forward to your continued support for this event in the future and for everything our industry is doing to support and elevate women in R&D, commercialization and leadership in our life sciences community.


Up Next - We look forward to seeing you at these events:

  • October 10: Virginia Bioscience Commercialization Luncheon in Richmond, feat. Former U.S. Navy Seal Dan Hathorn, Army Business Development Manager - Medical for Atlantic Diving Supply

  • January 12: Private Virginia Reception at the JP Morgan Healthcare Week in San Francisco

Our Virginia Reception on the eve of JP Morgan Healthcare week at the Velvet Room in the Clift Hotel is a rare opportunity to engage with Virginia industry leaders, emerging fast-growth companies and members of the investment community. This is a singularly unique opportunity for you to meet with scores of investors and potential collaborators, all in one place. Attendance is limited (and hotel rooms even more so!), so please be sure to mark your calendars, make your hotel reservations and start planning those private meetings!

Thank you for making Women Building Bio 2019 a success, and I look forward to seeing each of you at future events, and around our great community.

Kindest regards,


John

This post has not been tagged.

Share |
Permalink
 

Greeting from John Newby, new Viriginia Bio CEO

Posted By Administration, Friday, August 30, 2019
Updated: Monday, August 19, 2019

Members and Friends,

I bring you a hearty “Welcome!” from your Virginia Biotechnology Association! The welcome I have received from the Virginia Bio Board, our members and partners has been immensely enthusiastic, and the excitement around what we have accomplished and what we will do together is incredible. A special thanks to Alan Connor for his leadership of our Board, and also to immediate-past CEO Jeff Gallagher who remains engaged with our community and with me and the Association during this transition.


Perhaps the best way to look at life is through the eyes of a child. When I accepted the wonderful opportunity to lead Virginia Bio, my 10 year old daughter Jillian asked me “Dad, why Virginia Bio?” As is always the case with talking to the young (and young at heart) I had to answer in the most direct and simple way possible: “Because life science touches EVERYTHING!” From the care delivered by healthcare providers, to the medicines, pharmaceuticals and medical devices used to improve lives, to the food we eat, life science is of preeminent importance. Let’s continue to inform our neighbors of these truths, and attract youth and underrepresented groups into our life science community.

To this end, we look forward to you joining us at the 4th Annual Women Building Bio regional conference on Thursday, September 19th at the Inova Center for Personalized Health. The conference will spotlight women building our industry and create an enhanced opportunity for collaboration, networking and community building. The development of women in R&D and commercialization of bioscience is critical to all of our success. Patients are waiting, resources are limited, change is accelerating, and competition is global. We need to include, welcome and nurture all the talent we can to succeed as an industry and to best serve our patients and customers.

We are excited to have several national leaders in bioscience joining us, including:

Nancy Agee, CEO Carilion Clinic, Roanoke, currently Chair of the American Hospital Association and co-founder of the highly successful Virginia Tech Carilion public private partnership; and

Julie Gerberding, EVP Communications, Global Policy, and Population Health & Chief Patient Officer at Merck, Washington, DC. who last year was honored as the Healthcare Businesswomen's Association 2018 Woman of the Year;

Michelle McMurry-Heath, Worldwide Vice President for Regulatory, Preclinical, and Clinical Affairs and Global Head of Evidence Generation - Johnson & Johnson, and Vice President, External Innovation, Regulatory Science, and Executive Director Scientific Partnerships, JLABS@Washington DC at Johnson & Johnson.

You may find the agenda here. Register now, and contact Cassandra Isley to become a sponsor or exhibitor.

I look forward to seeing each of you at this and all future events, and around our great community. If I’m in your area, don’t be surprised to get a meeting request from me! And, as always, I am available to you at john.newby@vabio.org, 804.643.6360.

Yours in service,

 

John

This post has not been tagged.

Share |
Permalink
 

Women Building Bio 2019

Posted By Administration, Thursday, July 25, 2019
Updated: Wednesday, July 24, 2019

Dear Members and Friends,

We are thrilled to share news of the emerging agenda for the 4th Annual Women Building Bio regional conference on Thursday September 19 at Inova Center for Personalized Health. 

National leaders who call our region home will join with women leading bioscience commercialization and R&D from across Virginia, DC and Maryland to create this extraordinary event. 

Our three keynote presenters will be: 

Julie Gerberding, EVP Communications, Global Policy, and Population Health & Chief Patient Officer at Merck, Washington, DC. who last year was honored as the Healthcare Businesswomen's Association 2018 Woman of the Year.  Dr. Gerberding also has led BIO’s efforts to create and establish founding principles and operationalized its national Workplace Development, Diversity, and Inclusion initiative.

Nancy Agee, CEO Carilion Clinic, Roanoke, currently Chair of the American Hospital Association and co-founder of the highly successful Virginia Tech Carilion public private partnership, including the Fralin Biomedical Research Institute and an increasingly large number of spinouts. 

Michelle McMurry-Heath, Worldwide Vice President for Regulatory, Preclinical, and Clinical Affairs and Global Head of Evidence Generation - Johnson & Johnson, and Vice President, External Innovation, Regulatory Science, and Executive Director Scientific Partnerships, JLABS@Washington DC at Johnson & Johnson - a leader of JLABS@Washington DC at Children’s National Research and Innovation Campus at the former Walter Reed Army Hospital site.

 

We will have panels of women from across Virginia and the region who are leading bioscience commercialization and research.  They will highlight their breakthrough technologies, products and services, highlight collaborative opportunities, and offer insights from their professional and personal journeys. 

Finally, a favorite part of the program is TIES structured networking.  In the beautiful atrium area of the conference center we’ll reserve a dozen tables (rounds of 10), and each table will be anchored by a host -  a woman who is doing great things in the field in the region whom audience members would like to meet.  We’ll schedule two half-hour periods back to back in which 9 attendees can select and sit at one of the tables of their choice and meet and talk with the host in a small group setting.  Hosts come from a very wide range of roles and expertise, insights and potential contacts  - regulatory specialist, investor, Community College Dean, military science program officer, NIH and NSF program officers, university tech transfer, patient engagement specialist, etc.  Great connections are always made.

The goal of the day is to identify and showcase women building the industry across the region and nation and create a setting where they and the attendees can create new relationships and seed collaborations, and year over year build an ever-bigger community of connection and support to build better individuals, firms and industry, to better help patients and the people we serve.

If you’ve not seen it, look at the impressive community of women and men who have presented in our first three years of Women Building Bio conferences.  This year’s group will make it even stronger – come meet them in person on September 19!  

Register now, and contact Cassandra Isley to help support this unique and important event by exhibiting or sponsorships.

Best,

Jeff Gallagher

This post has not been tagged.

Share |
Permalink
 

Special Guest; Andrew Krouse

Posted By Andrew Krouse, Wednesday, June 26, 2019
Updated: Monday, June 24, 2019
Dear Friends,

As I complete my tenure, I want to thank each and every one of you for making Virginia Bio one of the leading life sciences associations in the country and for making my turn as Chairman so meaningful. I especially want to thank our executive committee, our board, our members, our sponsors and, most importantly the terrific team that consistently puts on fantastic programs for us. I am saddened to see Sherri Halloran leaving us after eleven years of dedicated and terrific work. She certainly has been a cornerstone of the organization, she will be missed, and we wish her the very best. You can see Sherri’s blog about her transition elsewhere in this newsletter. With the retirement of our beloved CEO Jeff Gallagher, it has been a busy time overseeing of the selection of a new CEO.

As I look back on my two years as Chairman and nearly a decade of volunteer service to the Board, I think fondly of the many professional and personal friendships I have made through the association. Virginia Bio is a very special organization that has allowed me to flourish both professionally and personally. I hope you share in my enthusiasm for Virginia Bio and the friendships that can be made through the organization. Generosity of spirit is a particular strength of our group – we all simultaneously mentor and learn from each other. I am proud of our work in helping Virginia companies gain more access to capital. Capital is the lifeblood of healthy biotech ecosystems. The annual JP Morgan reception has put Virginia Bio on the map and allowed entrepreneurs to mingle with some of the country’s top venture capitalists and corporate development professionals – many of whom have a tie back to Virginia. I am most proud of the creation of the Jeffrey Gallagher STEM Fellows Program. These scholarships will leave a lasting, generational impact on the individual students – perhaps changing their life’s trajectory – as well as hopefully the creation of new medicines, innovative research, novel devices and better agricultural products.

It is an exciting time at Virginia Bio. We were blessed to have had Jeff at the helm these last seven years as the organization took a great leap forward. Jeff leaves a very strong Virginia Bio – an organization that is thriving and healthy. I am pleased to announce that Jeff has agreed to work as a consultant to help in the transition of the new CEO as well as provide support on strategic activities. As we look to the future, knowing that Jeff and the team built a solid foundation, I am excited to think about the possibilities of where Virginia Bio is headed under the leadership of our new CEO. I ask each of you to think of ways we can improve Virginia Bio – to help shape it for the next decade. We are going to need your commitment to continue to help build Virginia Bio through your volunteer service and financial support. The new CEO is going to depend on our Board, our members, and our sponsors. Together we will shape the future of Virginia Bio!

I have loved my time with Virginia Bio and look forward to continuing to support its efforts. Please join me in welcoming Alan Connor into his new role as Chairman effective July 1st. I could not have asked for a better Vice Chairman than Alan. He is extremely thoughtful and disciplined in his approach to all matters and brings a fresh perspective to the organization. He will provide a steady hand as he and the new CEO help to advance the association within the Commonwealth.

Cheers,


Andrew Krouse

This post has not been tagged.

Share |
Permalink
 

NEW Gallagher Scholarship Fund for bioSTEM

Posted By Administration, Thursday, May 23, 2019
Updated: Wednesday, May 22, 2019
Dear Members and Friends,

Thanks for helping us make THRiVE 2019 a huge success! It was great to connect with so many of you and enjoy a day filled with dozens of industry leading CEOs, ground breaking panels and hot topic discussions. I hope you enjoyed the topics and much as I did on; Virginia’s bioscience transformations in artificial intelligence & data science, exploring the medical device & med tech boom, opportunities in helping to meet the biomedical needs of military and veterans and the impact of innovation on the opioid and addiction crisis. To see photos from THRiVE, click here.

INTRODUCING A NEW SCHOLARSHIP FUND-WE NEED YOUR HELP

Our hard work in the Foundation launched a new and exciting initiative at THRiVE, as I had the honor and privilege of revealing the new Jeff Gallagher STEM Scholarship Fund. This scholarship will provide summer bioscience camp opportunities to students whose families do not have the financial resources to pay for their children’s attendance. The camps provide real opportunities for children who are smart, willing and eager to have a chance at becoming future colleagues in our exciting, life-saving industry and here’s our chance to help.

Virginia Bio seeded the fund with $10,000, and the Board issued a challenge to raise a matching
$10,000 from attendees and members. I made a $1,000 donation as did several of our Board colleagues. For those of you who have already donated, THANK YOU! If you haven’t done so yet, we’ve made it very quick and easy to donate; simply click on Jeff Gallagher STEM Scholarship. We know the kids are so grateful for your support.

In addition to our work in STEM and workforce, the Foundation is the link to student chapters on campuses across the state. We are delighted to share that we recently received a letter from JMU Bio Chapter President, Kyle Sperber, reporting on the recently completed school year. I think you’ll be impressed to read about the student’s accomplishments and inspired by their enthusiasm for learning and interacting with members of industry. Take a minute to read this heartfelt letter by clicking here.

Lastly, I look forward to keeping everyone informed about all the progress of the Foundation initiatives. Fellow board members involved are Mark Herzog, kaleo and Denise Toney, Division of Consolidated Laboratory Services, Commonwealth of Virginia, and colleagues with colleges, universities and companies from around the state. If you would like to become involved, please let us know!

Sincerely,


Jim Powers
Chairman, Virginia BIO Foundation
Chairman and CEO, HemoShear Therapeutiucs

This post has not been tagged.

Share |
Permalink
 

Don't miss THRiVE 2019

Posted By Administration, Thursday, April 25, 2019

Dear members and friends,

Next Thursday, May 2, in Richmond a unique opportunity to hear from and meet 40 leaders of our industry in one place on one day.  It’s the biggest gathering of members of our industry in two years.

Make connections, learn actionable intelligence and get inspired by this intense power packed agenda and social gathering.   

You’ll get an in depth briefing on:

unprecedented efforts to make accessible the best-in-world data and AI capabilities in Ashburn to firms and researchers across the state and become home to the nation’s most ambitious and necessary bioinformatics projects;

new technological and collaborative tools Virginians are bringing to fight the complex addiction/opioid epidemic from the life science innovation industry. 

You’ll hear national level keynotes from:

Captain Joseph Cohen, who leads the Defense Health Agencies Defense Health Program Research and Development Portfolio - technologies sought and under development to meet the current and future health care needs of our military and their families;

Eric Major, a co-founder in 2004 of the NoVa startup K2M which designed, developed, and commercialized innovative complex spine and minimally invasive spine technologies, who led the company’ growth through the recent acquisition by Stryker for $1.4B, who now serves as President of Stryker’s Spine Division.  

Greg Crist, who leads national advocacy for AdvaMed, the med device / med tech industry’s leading advocate before policymakers in Washington, and our ally in Virginia.

You will get a first-time overview and in depth look at Virginia’s the med device / med tech industry, hear from a wide range of companies and researchers working across a range of technologies.

You’ll meet people behind exciting recent headlines of important new initiatives statewide, and award-winning lifetime achievements for outstanding contributions to the industry.

You’ll have the chance to network all day with connections from across the state.

Really, friends, it will be an extraordinary day.

So, check out the agenda in full, and register today.  See you there!

 

Best,

Jeff


This post has not been tagged.

Share |
Permalink
 

We need your help

Posted By Administration, Wednesday, March 27, 2019
Updated: Tuesday, March 26, 2019

Members and Friends,

By now many of you have received the news that I will be transitioning out of my CEO role at Virginia Bio, and many of you have called or written me. Thanks for those well wishes. And thanks for the opportunity to serve the life science community and witness your commitment to making the world a better place.

It has been a wonderful 7 years for me and, I think, for the organization as together, with our great staff, we’ve truly helped our members succeed and our industry thrive.

The future looks bright for this wonderful organization and the industry in Virginia, due to the solid foundation built through the efforts and support of you our collaborators, members and leaders. We have put Virginia on the life science map and we have learned how to collaborate better, how to shape and put forward a shared vision, craft and pursue strategies, contribute to the public policy process, serve our companies and drive the life science industry - all to help the people we ultimately serve.

But science changes, business and politics change, the set of possibilities changes, and it’s time for a change for us, to a new CEO, who will be as dedicated to Virginia Bio’s mission as any of us has ever been, but with a personality, vision, and skill set of their own ready to race after the new opportunities that change offers and demands. And it’s time for me to listen for the next calling.

I will continue to lead the organization until our new CEO is in place. I’ll stay on as a special assistant to the CEO to help get her or him up to speed and meet our members and stakeholders, then I’ll continue part-time to continue Virginia Bio’s involvement on several initiatives with statewide significance.

Your help is critical. Help us find the next CEO. Please forward news of the opening to outstanding candidates you may know. It is likely (we’ve been counseled) that the successful candidate will emerge from a connection with one of our members or stakeholders. Here is the link.

Moving ahead strongly as we search.
Staff has worked overtime to assure that we are all set to have a robust schedule of programs and services for the year ahead during the search and onboarding of the new CEO. Please use and enjoy them.

THRiVE 2019
Virginia Bio’s biannual statewide flagship conference, will be held in Richmond on May 2. There’s an extraordinary agenda planned, and terrific networking opportunities to connect you with colleagues across the state and open opportunities for you.

Also, the annual BioHealth Capital Region Forum, which we are co-sponsoring with colleagues in Maryland and DC in Gaithersburg, MD on April 8-9; Women Building Bio: all day regional conference is set for September 19 at Inova Center for Personalized Health; and we have the signed contract in hand for the Virginia Reception and meeting rooms at the Clift Hotel during JPMorgan in San Francisco next January. In addition, we are busy scheduling the next year’s luncheons and networking events in NoVa, Charlottesville, Hampton Roads, Roanoke/Blacksburg and Richmond, webinars and our STEM and workforce efforts through the Foundation.

My sincere thanks for your support of Virginia Bio. I consider myself blessed to have had the opportunity to work on your behalf and get to know so many of you. I look forward to watching each of you and this irreplaceable organization thrive in the years to come.

Best regards,

 

 

Jeff Gallagher

This post has not been tagged.

Share |
Permalink
 
Page 1 of 7
1  |  2  |  3  |  4  |  5  |  6  |  7

Our Premium Partners

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected